Lupin gets US FDA nod for oral contraceptive generic

Lupin's subsidiary Lupin Pharmaceuticals Inc has received US Food and Drug Administration approval to sell Norgestimate and Ethinyl Estradiol tablets in various strengths.

July 03, 2012 / 18:08 IST

Moneycontrol Bureau

Lupin's subsidiary Lupin Pharmaceuticals Inc has received US Food and Drug Administration approval to sell Norgestimate and Ethinyl Estradiol tablets in various strengths.

Lupin's Norgestimate and Ethinyl Estradiol tablets are the generic equivalent of Ortho Tri-cyclen Lo tablets of Janssen Pharmaceuticals and are indicated for prevention of pregnancy in women who choose oral contraceptives as a method of contraception.

Ortho Tri-cyclen Lo tablets had annual sales of about USD 421 million in the US market for year ended March 2012, Lupin said, citing IMS Health data.

Lupin shares were down 0.7% at Rs 540 on NSE in afternoon trade.

first published: Jul 3, 2012 02:16 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Email address

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347